These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12582325)

  • 1. Conjunctival provocation testing: overview of recent clinical trials in ocular allergy.
    Friedlaender MH
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):413-7. PubMed ID: 12582325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conjunctival provocation test].
    Mortemousque B
    J Fr Ophtalmol; 2007 Mar; 30(3):300-5. PubMed ID: 17417158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic conjunctivitis and conjunctival provocation tests in atopic dogs.
    Lourenço-Martins AM; Delgado E; Neto I; Peleteiro MC; Morais-Almeida M; Correia JH
    Vet Ophthalmol; 2011 Jul; 14(4):248-56. PubMed ID: 21733066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival provocation test as a model for the study of allergy and inflammation in humans.
    Bonini S; Bonini S; Berruto A; Tomassini M; Carlesimo S; Bucci MG; Balsano F
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):144-8. PubMed ID: 2651314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conjunctival provocation test with standardised allergens extracts].
    Górska A; Chełmińska M
    Pneumonol Alergol Pol; 2007; 75(3):273-7. PubMed ID: 17966104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctival allergen provocation test : guidelines for daily practice.
    Fauquert JL; Jedrzejczak-Czechowicz M; Rondon C; Calder V; Silva D; Kvenshagen BK; Callebaut I; Allegri P; Santos N; Doan S; Perez Formigo D; Chiambaretta F; Delgado L; Leonardi A;
    Allergy; 2017 Jan; 72(1):43-54. PubMed ID: 27430124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival provocation testing: overview of recent clinical trials in ocular allergy.
    Friedlaender MH
    Int Ophthalmol Clin; 2003; 43(1):95-104. PubMed ID: 12544398
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
    Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
    Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival provocation tests: prediction of seasonal allergy.
    Schröder J; Mösges R
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):393-397. PubMed ID: 30020256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of three antiallergic eyedrops in a specific conjunctival provocation test: mequitazine, levocabastine and dexamethasone].
    Richard C; Bibas P; Lablache-Combier M; Allaire C
    J Fr Ophtalmol; 2005 Mar; 28(3):244-50. PubMed ID: 15883488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo diagnostic measurements of ocular inflammation.
    Leonardi A
    Curr Opin Allergy Clin Immunol; 2005 Oct; 5(5):464-72. PubMed ID: 16131925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.
    Abelson M; Howes J; George M
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):533-42. PubMed ID: 9867336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival effects of a selective nasal pollen provocation.
    Callebaut I; Spielberg L; Hox V; Bobic S; Jorissen M; Stalmans I; Scadding G; Ceuppens JL; Hellings PW
    Allergy; 2010 Sep; 65(9):1173-81. PubMed ID: 20415718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current opinion of immunotherapy for ocular allergy.
    Bielory L; Mongia A
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):447-52. PubMed ID: 12582330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
    Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
    Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
    Kruse K; Gerwin E; Eichel A; Shah-Hosseini K; Mösges R
    J Allergy Clin Immunol Pract; 2015; 3(3):381-6. PubMed ID: 25609338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy for treating allergic conjunctivitis.
    Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham S
    Cochrane Database Syst Rev; 2011 Jul; (7):CD007685. PubMed ID: 21735416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to the allergen conjunctival provocation test.
    Mourão EM; Rosário NA
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):373-4. PubMed ID: 21962101
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of the conjunctival provocation test in evaluating the activity of 2 concentrations of anti-allergy eyedrops, mequitazine].
    Dupin O; Compeyre S; Trinquand C; Persi L; Arnaud B
    J Fr Ophtalmol; 1998 Jan; 21(1):12-8. PubMed ID: 9834894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.
    Abelson MB; Spitalny L
    Am J Ophthalmol; 1998 Jun; 125(6):797-804. PubMed ID: 9645717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.